Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,391,411
+$10,534,316 QoQ
Shares Held
13,666
+114.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#994
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. LLY ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,391,411 | 13,666 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,857,095 | 6,368 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,056,349 | 6,566 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,393,647 | 7,069 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,158,929 | 6,618 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,458,439 | 6,609 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,276,108 | 5,539 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,815,969 | 5,436 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,605,668 | 5,087 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $3,962,928 | 5,094 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,126,199 | 5,363 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,717,877 | 5,060 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,360,845 | 5,034 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,487,352 | 4,331 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,575,307 | 4,306 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,416,596 | 4,381 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,420,451 | 4,381 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,260,314 | 4,401 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,295,471 | 4,690 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,082,007 | 4,683 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $670,886 | 2,923 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $825,370 | 4,418 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $795,742 | 4,713 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $688,144 | 4,649 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $755,392 | 4,601 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $641,025 | 4,621 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||